|
Volumn 822, Issue 1-2, 2005, Pages 201-208
|
Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction
|
Author keywords
Antiretroviral; Chromatography; HIV; HPLC; NRTI; NtRTI
|
Indexed keywords
BIOASSAY;
BLOOD;
BODY FLUIDS;
CONCENTRATION (PROCESS);
EXTRACTION;
METHANOL;
PHARMACOKINETICS;
PHOSPHATES;
HUMAN BLOOD PLASMA;
PHOSPHATE BUFFER;
SOLID-PHASE EXTRACTION (SPE) METHOD;
THERAPEUTIC DRUG MONITORING;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
2',3' DIDEOXYURIDINE;
BUFFER;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
METHANOL;
PHOSPHATE;
TENOFOVIR;
TENOFOVIR DISOPROXIL;
URIDINE DERIVATIVE;
ACCURACY;
ARTICLE;
COLUMN CHROMATOGRAPHY;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
ELUTION;
EXTRACTION;
HUMAN;
PH;
PLASMA;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
QUANTITATIVE ASSAY;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SOLID PHASE EXTRACTION;
STANDARD;
VALIDATION PROCESS;
ADENINE;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DEOXYCYTIDINE;
DRUG STABILITY;
HUMANS;
PHOSPHONIC ACIDS;
REVERSE TRANSCRIPTASE INHIBITORS;
SENSITIVITY AND SPECIFICITY;
|
EID: 22244445149
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2005.06.019 Document Type: Article |
Times cited : (95)
|
References (12)
|